10x Seeks Reversal of Patent Infringement Verdict in Bio-Rad Case Under the Assignor Estoppel Ruling by SCOTUS
shot by IP News Shots / 6:01 pm on 14 July, 2021
10x Genomics, Inc. has approached the US Court of Appeals for the Federal Circuit (CAFC) urging it to review an earlier ruling by the court which upheld the US International Trade Commission’s (ITC’s) decision favouring Bio-Rad Laboratories Inc. 10x was found guilty of infringing on Bio-Rad’s patents for gene sequencing chips but the former challenged the patents, which was refused by the commission. In its present appeal, 10x is using the assignor estoppel ruling by the Supreme Court of the US (SCOTUS) in hope of challenging the Bio-Rad patents.
Industry: Biotechnology, Healthcare Technology
Read more at Law360